No Record Found
Sector
PharmaceuticalsOpen
₹290.3Prev. Close
₹289.65Turnover(Lac.)
₹1.8Day's High
₹306.8Day's Low
₹290.352 Week's High
₹51152 Week's Low
₹271.1Book Value
₹232.38Face Value
₹10Mkt Cap (₹ Cr.)
91.15P/E
18.58EPS
15.59Divi. Yield
0.35No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 68.71 | 61.91 | 60.05 | 43.73 | 
| Net Worth | 71.8 | 65 | 63.14 | 46.82 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
| Revenue | 179.01 | 137.45 | 111.13 | 92.52 | 
| yoy growth (%) | 30.23 | 23.67 | 20.12 | 30.19 | 
| Raw materials | -164.24 | -125.61 | -102.62 | -81.92 | 
| As % of sales | 91.74 | 91.38 | 92.33 | 88.54 | 
| Employee costs | -1.49 | -1.44 | -1.38 | -1.29 | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
| Profit before tax | 7.36 | 5.79 | 2.15 | 4.92 | 
| Depreciation | -0.49 | -0.42 | -0.41 | -0.41 | 
| Tax paid | -2.01 | -1.54 | -0.62 | -1.7 | 
| Working capital | 3.61 | 5.53 | -1.22 | 5.89 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 30.23 | 23.67 | 20.12 | 30.19 | 
| Op profit growth | 30.75 | 108.66 | -46.6 | 61.6 | 
| EBIT growth | 27.49 | 110.67 | -44.39 | 69.61 | 
| Net profit growth | 25.87 | 175.9 | -52.26 | 83.35 | 
No Record Found
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.6 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,653.65 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.5 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,600.9 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,445.75 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Lalit Mehta
Director & CFO
Rajesh Mehta
Independent Director
Renu P Dharod
Executive Director
Megh Mehta
Company Sec. & Compli. Officer
Nishant Kankaria
Plot No A2/3445,
GIDC Phase IV,
Gujarat - 393002
Tel: 91-2646-220774
Website: http://www.samratpharmachem.com
Email: contact@samratpharmachem.in
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Samrat Pharmachem Limited was incorporated on June 16, 1992. The Companys principal activities are manufacturing and selling chemicals.The Company floated a new 100% subsidiary company during the year...
Read More
Reports by Samrat Pharmachem Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.